Insulet and Dexcom Partner to Offer Choices for Animas Users

Insulet Corporation, developer of tubeless insulin pump technology with its Omnipod Insulin Management System (Omnipod System), is partnering with DexCom Inc. to provide the Omnipod System and a $200 gift card from Dexcom which can be used towards the purchase of a Dexcom G5 Mobile CGM (Continuous Glucose Monitoring) for qualified Animas insulin pump users.¹ The program provides Animas users with an easy way to experience freedom from tubing and the ability to dose insulin without finger pricks.
 
The Omnipod Welcome Program includes a no cost trial of the Omnipod System, a free box of Pods (10 count), and the opportunity to receive a $200 gift card for completing a Dexcom patient survey to upgrade to the Dexcom G5 CGM.² Animas pump switchers who have recently taken advantage of the existing Omnipod Welcome Program may still take advantage of this Dexcom offer as long as they are not an already-existing customer of Dexcom.
 
“We created this program to provide a way for Animas users to experience the freedom of the Omnipod System with the peace of mind of Dexcom’s market-leading CGM,” said Bret Christensen, chief commercial officer of Insulet. “Managing diabetes is a very personal decision and we strongly support an individual’s right to choice when it comes to their diabetes management. This partnership is just one example of our commitment to support people with diabetes today and over the long term.”
 
“Dexcom is excited to partner with Insulet to offer this special promotion,” said Rick Doubleday, chief commercial officer of Dexcom. “This provides Animas users the opportunity to upgrade to our best-selling Dexcom G5 Mobile CGM and have easier access to the only tubeless pump system in the U.S.”
 
As the number one pediatric preferred pump³, which is also quickly gaining adoption with adults, the Omnipod System uses a tubeless, waterproof patch-pump technology that offers users significant quality of life benefits. The differentiated design provides up to 72 hours of nonstop, discreet insulin delivery, and more choice for site selection. It eliminates the burden associated with multiple daily injections and the complexity associated with traditional tubed pumps. When used with the Dexcom G5 Mobile CGM, users will benefit from fewer finger sticks, fewer components to carry and wear, and access to pump and blood glucose data from their smart-phone with Insulet provided Glooko.
 
References
¹The Omnipod Insulin Management System and the Dexcom G5 CGM are not integrated, are sold separately, and function independently.
²These promotions are two independent offerings and therefore an individual may take advantage of either one separately or both. You may be required to submit a form directly to Dexcom.
³dQ&A Q3 2016 Patient Panel Survey. Share of parents of children with type 1 diabetes on an insulin pump who had chosen the Omnipod was higher than for other pumps. Statistical significance of results calculated at the 95 percent confidence level.